508.80
+5.55(+1.10%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2875
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Mr. Scott B. Delaney | President of North America & Chief Executive Officer of North America | 0 | 1969 |
| Dr. P. B. Deshpande M.Sc. Ph.D. | Vice President of Chemical of Research and Development | 593,349 | 1955 |
| Mr. Vinod Kumar Behl | Head of Projects & Investments | 2.1M | 1950 |
| Mr. Pradeep Kumar Bhandari | Head of Legal, Company Secretary & Compliance Officer | 9.84M | 1958 |
| Mr. Pabitra Kumar Kalipada Bhattacharya | MD & Director | 29.18M | 1969 |
| Dr. Ashwani Kumar | Chief Manufacturing & Compliance Officer | 0 | N/A |
| Mr. Bhagwat S. Dhingra | Chief Executive of Domestic Pharma | 0 | 1963 |
| Mr. Jalesh Burye | Chief Quality & Compliance Officer | 0 | N/A |
| Mr. Prasad Joshi | Vice President of Human Resources & ER | 0 | 1958 |
| Dr. Dhananjay Sathe | Chief Scientific & Compliance Officer | 0 | N/A |
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.